Background Advances in cancer genome sequencing have led to the development of
various next-generation sequencing (NGS) platforms. There is paucity of data regarding …

Context.—Bladder cancer is a heterogeneous disease that exhibits a wide spectrum of
clinical and pathologic features. The classification of bladder cancer has been traditionally …

Urothelial bladder cancers (UBCs) have heterogeneous clinical characteristics that are
mirrored in their diverse genomic profiles. Genomic profiling of UBCs has the potential to …

Urothelial bladder cancer (UBC) is one of the most common lethal cancer worldwide and the
5-year survival rate has not improved significantly with current treatment protocols during the …

Urothelial bladder cancer (UC) has a wide tumor biological spectrum with challenging
prognostic stratification and relevant therapy-associated morbidity. Most molecular …

The progression of bladder cancer is generally a complex and dynamic process, involving a
variety of biological factors. Here, we aimed to identify a set of survival-related genes that …

Recent genomic analyses have revealed that the classification of urothelial carcinoma is
much more complex than the traditional dichotomy of nonmuscle-invasive and muscle …

With recent advancements in a non-invasive approach to cancer diagnosis and surveillance,
the term “liquid biopsy” has gained traction but is currently limited by technological …

Bladder cancer is a heterogeneous disease, which exhibits a wide spectrum of clinical and
pathologic features. Recent genomic studies have revealed that distinct molecular …

Simple Summary Urothelial cell carcinoma (UCC) is the ninth most common cancer
worldwide and in the US the fourth most common cancer, with~ 82,000 new cases (~ 62,000 …